Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

P. Doležalová, M. Bohm, L. Linková, M. Saifrídová, D. Němcová, T. Dallos, A. Consolaro, F. Bovis, N. Ruperto, . ,

. 2018 ; 38 (Suppl 1) : 123-130. [pub] 20180407

Language English Country Germany

Document type Journal Article, Multicenter Study, Validation Study

E-resources Online Full text

NLK ProQuest Central from 1997-03-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-12-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-03-01 to 1 year ago

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient-reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Czech language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. The participating centre was asked to collect demographic and clinical data along the JAMAR questionnaire in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability, and construct validity (convergent and discriminant validity). A total of 103 JIA patients (5.8% systemic, 35.9% oligoarticular, 37.9% RF-negative polyarthritis, 20.4% other categories) and 100 healthy children, were enrolled. The JAMAR components discriminated well healthy subjects from JIA patients. Notably, there was no significant difference between healthy subjects and their affected peers in the school-related problems variable and in the Psychosocial Health of the Paediatric Rheumatology Quality of Life scale. All JAMAR components revealed good psychometric performances. In conclusion, the Czech version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033171
003      
CZ-PrNML
005      
20191021090856.0
007      
ta
008      
181008s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00296-018-3969-5 $2 doi
035    __
$a (PubMed)29637350
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Doležalová, Pavla $u Department of Paediatrics and Adolescent Medicine, 1st Faculty of Medicine, General University Hospital, Charles University in Prague, Ke Karlovu 2, 121 09, Prague, Czech Republic. dolezalova.pavla@vfn.cz.
245    14
$a The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) / $c P. Doležalová, M. Bohm, L. Linková, M. Saifrídová, D. Němcová, T. Dallos, A. Consolaro, F. Bovis, N. Ruperto, . ,
520    9_
$a The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient-reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Czech language. The reading comprehension of the questionnaire was tested in ten JIA parents and patients. The participating centre was asked to collect demographic and clinical data along the JAMAR questionnaire in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the three Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability, and construct validity (convergent and discriminant validity). A total of 103 JIA patients (5.8% systemic, 35.9% oligoarticular, 37.9% RF-negative polyarthritis, 20.4% other categories) and 100 healthy children, were enrolled. The JAMAR components discriminated well healthy subjects from JIA patients. Notably, there was no significant difference between healthy subjects and their affected peers in the school-related problems variable and in the Psychosocial Health of the Paediatric Rheumatology Quality of Life scale. All JAMAR components revealed good psychometric performances. In conclusion, the Czech version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research.
650    _2
$a mladiství $7 D000293
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a juvenilní artritida $x diagnóza $x patofyziologie $x psychologie $x terapie $7 D001171
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kulturní charakteristiky $7 D003466
650    _2
$a Česká republika $7 D018153
650    12
$a posuzování pracovní neschopnosti $7 D004185
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zdravotní stav $7 D006304
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a rodiče $x psychologie $7 D010290
650    12
$a hodnocení výsledků péče pacientem $7 D000071066
650    _2
$a pacienti $x psychologie $7 D010361
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a prognóza $7 D011379
650    _2
$a psychometrie $7 D011594
650    _2
$a kvalita života $7 D011788
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a revmatologie $x metody $7 D012219
650    _2
$a překládání $7 D014175
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a validační studie $7 D023361
700    1_
$a Böhm, Marek $7 xx0240917 $u Department of Paediatrics and Adolescent Medicine, 1st Faculty of Medicine, General University Hospital, Charles University in Prague, Ke Karlovu 2, 121 09, Prague, Czech Republic.
700    1_
$a Linková, Lenka $u Department of Paediatrics and Adolescent Medicine, 1st Faculty of Medicine, General University Hospital, Charles University in Prague, Ke Karlovu 2, 121 09, Prague, Czech Republic.
700    1_
$a Saifrídová, Melánia $u Department of Paediatrics and Adolescent Medicine, 1st Faculty of Medicine, General University Hospital, Charles University in Prague, Ke Karlovu 2, 121 09, Prague, Czech Republic.
700    1_
$a Němcová, Dana $u Department of Paediatrics and Adolescent Medicine, 1st Faculty of Medicine, General University Hospital, Charles University in Prague, Ke Karlovu 2, 121 09, Prague, Czech Republic.
700    1_
$a Dallos, Tomáš $u Department of Paediatrics, Comenius University Medical School in Bratislava, Bratislava, Slovakia.
700    1_
$a Consolaro, Alessandro $u Clinica Pediatrica e Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto Giannina Gaslini, Via Gaslini 5, 16147, Genoa, Italy. Dipartimento di Pediatria, Università di Genova, Genoa, Italy.
700    1_
$a Bovis, Francesca $u Clinica Pediatrica e Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto Giannina Gaslini, Via Gaslini 5, 16147, Genoa, Italy.
700    1_
$a Ruperto, Nicolino $u Clinica Pediatrica e Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO), Istituto Giannina Gaslini, Via Gaslini 5, 16147, Genoa, Italy. nicolaruperto@gaslini.org.
700    1_
$a ,
773    0_
$w MED00004228 $t Rheumatology international $x 1437-160X $g Roč. 38, Suppl 1 (2018), s. 123-130
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29637350 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20191021091329 $b ABA008
999    __
$a ok $b bmc $g 1340038 $s 1030165
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 38 $c Suppl 1 $d 123-130 $e 20180407 $i 1437-160X $m Rheumatology international $n Rheumatol Int $x MED00004228
LZP    __
$a Pubmed-20181008

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...